Jetrea 0.5mg/0.2ml Injection
Ocriplasmin
0.5mg/0.2ml
ALCON-COUVREUR
| Pack size | 0.2ml Glass Vial |
|---|---|
| Dispensing mode | POM |
| Source | BELGIUM |
| Agent | ALPHAMED DRUG STORE |
| Retail Price | 19016.50 AED |
Indications
Jetrea 0.5mg/0.2ml Injection is used for:
Ocriplasmin is a proteolytic enzyme indicated for the treatment for symptomatic vitreomacular adhesion.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Ocriplasmin :
Mechanism of Action
Ocriplasmin has proteolytic activity against protein components of the vitreous body and the vitreoretinal interface (VRI) (e.g. laminin, fibronectin and collagen), thereby dissolving the protein matrix responsible for the vitreomacular adhesion (VMA).
Note
Jetrea 0.5mg/0.2ml 0.5mg/0.2ml Injection manufactured by ALCON-COUVREUR. Its generic name is Ocriplasmin. Jetrea 0.5mg/0.2ml is availble in United Arab Emirates.
Farmaco UAE drug index information on Jetrea 0.5mg/0.2ml Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.